Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-026617)

Filing Details

Accession Number:: 0001209191-20-026617
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-01 18:00:15
Reporting Period:: 2020-04-29

Accepted Time:: 2020-05-01 18:00:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070494	Acadia Pharmaceuticals Inc	ACAD	Pharmaceutical Preparations (2834)	061376651

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1131146	Stephen Davis	C/O Acadia Pharmaceuticals Inc. 3611 Valley Centre Drive, Ste. 300 San Diego CA 92130	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-29	15,625	$0.00	18,579	No	4	M	Direct
Common Stock	Disposition	2020-04-30	6,770	$49.21	11,809	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-04-29	15,625	$0.00	15,625	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,875			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
The restricted stock units vest in four equal annual installments beginning 4/29/2020.